Evaluation for NCI Surgery Branch Clinical Research Protocols

Launched by NATIONAL CANCER INSTITUTE (NCI) · Nov 3, 1999

Keywords

ClinConnect Summary

This clinical trial, led by the National Cancer Institute Surgery Branch (NCI-SB), is exploring new experimental treatments for various types of cancer, including synovial cell cancer, melanoma, colorectal cancer, lung cancer, and bladder cancer. The main goal is to see if taking white blood cells from patients, growing them in the lab, and then giving them back can help treat their cancer. If you are 18 years or older and have been diagnosed with cancer, you might be eligible to participate in this study.

Participants will undergo some tests and evaluations to determine if they meet the requirements for the specific NCI-SB treatment protocol. It's important to know that women who are pregnant or planning to become pregnant cannot participate due to potential risks from some of the tests. If you qualify, you will receive detailed information about what to expect during the trial and how it might help in your cancer treatment journey. The study is currently recruiting participants, and everyone is welcome, regardless of gender.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Age \>= 18 years.
• • Patient suspected of having, or with biopsy proven, malignant disease.
• • Patient is able to understand and willing to sign a written informed consent document.
• • Patient is being evaluated for treatment on an NCI-SB protocols.
• EXCLUSION CRITERIA:
• • Women of child-bearing potential who are pregnant or plan to become pregnant because of the potentially dangerous effects of some of the screening procedures (e.g., nuclear medicine or other imaging scans) on the fetus.

Trial Officials